The genetic architecture of Plakophilin 2 cardiomyopathy

Regeneron Genetics Ctr, Annika M. Dries, Anna Kirillova, Chloe M. Reuter, John Garcia, Hana Zouk, Megan Hawley, Brittney Murray, Crystal Tichnell, Kalliopi Pilichou, Alexandros Protonotarios, Argelia Medeiros-Domingo, Melissa A. Kelly, Aris Baras, Jodie Ingles, Christopher Semsarian, Barbara Bauce, Rudy Celeghin, Cristina Basso, Jan D. H. JongbloedRobert L. Nussbaum, Birgit Funke, Marina Cerrone, Luisa Mestroni, Matthew R. G. Taylor, Gianfranco Sinagra, Marco Merlo, Ardan M. Saguner, Perry M. Elliott, Petros Syrris, J. Peter van Tintelen, Cynthia A. James, Christopher M. Haggerty, Victoria N. Parikh*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
32 Downloads (Pure)

Abstract

Purpose The genetic architecture of Plakophilin 2 (PKP2) cardiomyopathy can inform our understanding of its variant pathogenicity and protein function. Methods We assess the gene-wide and regional association of truncating and missense variants in PKP2 with arrhythmogenic cardiomyopathy (ACM), and arrhythmogenic right ventricular cardiomyopathy (ARVC) specifically. A discovery data set compares genetic testing requisitions to gnomAD. Validation is performed in a rigorously phenotyped definite ARVC cohort and non-ACM individuals in the Geisinger MyCode cohort. Results The etiologic fraction (EF) of ACM-related diagnoses from truncating variants in PKP2 is significant (0.85 [0.80,0.88], p < 2 x 10(-16)), increases for ARVC specifically (EF = 0.96 [0.94,0.97], p < 2 x 10(-16)), and is highest in definite ARVC versus non-ACM individuals (EF = 1.00 [1.00,1.00], p < 2 x 10(-16)). Regions of missense variation enriched for ACM probands include known functional domains and the C-terminus, which was not previously known to contain a functional domain. No regional enrichment was identified for truncating variants. Conclusion This multicohort evaluation of the genetic architecture of PKP2 demonstrates the specificity of PKP2 truncating variants for ARVC within the ACM disease spectrum. We identify the PKP2 C-terminus as a potential functional domain and find that truncating variants likely cause disease irrespective of transcript position.

Original languageEnglish
Pages (from-to)1961-1968
Number of pages8
JournalGenetics in Medicine
Volume23
Issue number10
DOIs
Publication statusPublished - Oct-2021

Keywords

  • MUTATIONS
  • VARIANTS

Fingerprint

Dive into the research topics of 'The genetic architecture of Plakophilin 2 cardiomyopathy'. Together they form a unique fingerprint.

Cite this